P3.02c-051 A Pre-Treatment Serum Test Based on Complement and IL-10 Pathways Identifies Patients Benefiting from the Addition of Bavituximab to Docetaxel: Topic: IT
Saved in:
Published in | Journal of thoracic oncology Vol. 12; no. 1; pp. S1305 - S1306 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.01.2017
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 1556-0864 1556-1380 |
---|---|
DOI: | 10.1016/j.jtho.2016.11.1846 |